About City of Hope

City of Hope is an independent biomedical research and treatment organization for cancer, diabetes and other life-threatening diseases.

Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution.  AccessHope™, a subsidiary launched in 2019 serves employers and their health care partners by providing access to City of Hope’s specialized cancer expertise.

A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.

City of Hope’s commitment to Diversity, Equity and Inclusion

We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all of our communities.  Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds and experiences to our work -- and that our teams align with the people we serve in order to build trust and understanding.  We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds and perspectives; this is reflected in our work and represented in our people.

Position Summary

The department of pathology of the City of Hope Medical center is recruiting a postdoctoral fellow to work with a group of researchers in lymphoma genomics and biology.

The candidate is expected to be an innovative scientist with knowledge and experience in molecular biology, cell culture, in vitro functional assays and genomic editing. Some interests and knowledge in the analysis of data generated through next generation sequencing and other global technologies including transcriptomic and mutational analysis as well as correlative analysis of different datasets would be desirable. A good understanding of general biological processes and immunology is highly desirable. Our group works very collaboratively in a supportive and stimulatory environment with the goal of understanding the pathogenesis of lymphoma, discovering novel therapeutic targets and improving the treatment and outcome of lymphoma patients.

Basic education, experience and skills required for consideration:

• A Ph.D. degree in life or biology, genomics/genetics or a related discipline is required.
• Experience using Next-Generation sequencing analysis and gene editing in lab investigation
• Experience in cell culture including the in vitro propagation, manipulation and characterization of lymphocytes.
• Proficient in molecular biological techniques including transfection, transduction, cloning, vector construction, reporter assay and western blot.
• Ability and interest in developing new assays as needed
• Basic proficiency in programming desirable
• Values research integrity, careful experimental work and collaborative research

Additional Information:

• For more information on Dr. John Chan’s research, please visit here.
• As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.

City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer.  All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.

#PD